References
- Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999 Aug;10(4):282–88. doi:https://doi.org/10.1097/00055735-199908000-00011.
- Papadia M, Barabino S, Valente C, Rolando M. Anatomical and immunological changes of the cornea in patients with pterygium. Curr Eye Res. 2008 May;33(5):429–34. doi:https://doi.org/10.1080/02713680802130354.
- Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf. 2008 Jan;6(1):24–43.
- Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol. 2000 Feb;84(2):212–16. doi:https://doi.org/10.1136/bjo.84.2.212.
- Liang K, Jiang Z, Ding BQ, Cheng P, Huang DK, Tao LM. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva. Mol Vis. 2011;17:1687–93.
- Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004 Nov 18;432(7015):307–15. doi:https://doi.org/10.1038/nature03098.
- Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008 Jan;9(1):47–59. doi:https://doi.org/10.1038/nrm2308.
- Warren CFA, Wong-Brown MW, Bowden NA. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis. 2019 Feb 21;10(3):177. doi:https://doi.org/10.1038/s41419-019-1407-6.
- Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009 Feb 15;15(4):1126–32. doi:https://doi.org/10.1158/1078-0432.CCR-08-0144.
- Turan M, Turan G. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence. Eur J Ophthalmol. 2020 Nov 30(6):1232-1237.
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004 Jan 23;116(2):281–97. doi:https://doi.org/10.1016/S0092-8674(04)00045-5.
- Lan W, Chen S, Tong L. MicroRNA-215 regulates fibroblast function: insights from a human fibrotic disease. Cell Cycle. 2015;14(12):1973–84. doi:https://doi.org/10.1080/15384101.2014.998077.
- Engelsvold DH, Utheim TP, Olstad OK, Gonzalez P, Eidet JR, Lyberg T, Trøseid AM, Dartt DA, Raeder S. miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium. Exp Eye Res. 2013 Oct;115:189–98. doi:https://doi.org/10.1016/j.exer.2013.07.003.
- Lee JH, Jung SA, Kwon YA, Chung JL, Kim US. Expression of microRNAs in fibroblast of pterygium. Int J Ophthalmol. 2016 Jul 18;9(7):967–72.
- Cui YH, Li HY, Gao ZX, Liang N, Ma SS, Meng FJ, Li ZJ, Pan HW. Regulation of apoptosis by miR-122 in Pterygium via targeting Bcl-w. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3723–30. doi:https://doi.org/10.1167/iovs.16-19402.
- Wu CW, Cheng YW, Hsu NY, Yeh KT, Tsai YY, Chiang CC, Wang WR, Tung JN. MiRNA-221 negatively regulated downstream p27Kip1 gene expression involvement in pterygium pathogenesis. Mol Vis. 2014 Jul 21;20:1048–56.
- Chien KH, Chen SJ, Liu JH, Woung LC, Chen JT, Liang CM, Chiou SH, Tsai CY, Cheng CK, Hu CC, et al. Correlation of microRNA-145 levels and clinical severity of pterygia. Ocul Surf. 2013 Apr;11(2):133–38. doi:https://doi.org/10.1016/j.jtos.2012.12.001.
- Pekarsky Y, Balatti V, Croce CM. BCL2 and miR-15/16: from gene discovery to treatment. Cell Death Differ. 2018 Jan;25(1):21–26. doi:https://doi.org/10.1038/cdd.2017.159.
- Tang J, Wang Z, Chen L, Huang G, Hu X. Gossypol acetate induced apoptosis of pituitary tumor cells by targeting the BCL-2 via the upregulated microRNA miR-15a. Int J Clin Exp Med. 2015 Jun 15;8(6):9079–85.
- Li Y, Zhang B, Li W, Wang L, Yan Z, Li H, Yao Y, Yao R, Xu K, Li Z. MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma. Leuk Res. 2016 Oct;49:73–79. doi:https://doi.org/10.1016/j.leukres.2016.08.013.
- Li X, Dai Y, Xu J. MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway. Mol Vis. 2018 Jul 23;24:485–94.
- He S, Huang Y, Dong S, Qiao C, Yang G, Zhang S, Wang C, Xu Y, Zheng F, Yan M. MiR-199a-3p/5p participated in TGF-β and EGF induced EMT by targeting DUSP5/MAP3K11 in pterygium. J Transl Med. 2020 Sep 1;18(1):332. doi:https://doi.org/10.1186/s12967-020-02499-2.
- He S, Sun H, Huang Y, Dong S, Qiao C, Zhang S, Wang C, Zheng F, Yan M, Yang G. Identification and interaction analysis of significant genes and microRNAs in Pterygium. Biomed Res Int Biomed Res Int. 2019 Jun;25(2019):2767512.
- Yue J, Tigyi G. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters. Mamm Genome. 2010 Feb;21(1–2):88–94. doi:https://doi.org/10.1007/s00335-009-9240-3.
- Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998 Aug 28;281(5381):1322–26. doi:https://doi.org/10.1126/science.281.5381.1322.
- Ye EA, Liu L, Steinle JJ. miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins. Vision Res. 2017 Oct;139:23–29. doi:https://doi.org/10.1016/j.visres.2017.07.007.